$SMLR
Semler Scientific, Inc.

2024 Q2 Form 10-Q Financial Statement

#000155485924000017 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $14.47M $15.90M
YoY Change -22.25% -12.65%
Cost Of Revenue $1.255M $1.247M
YoY Change 2.95% -1.73%
Gross Profit $13.21M $14.66M
YoY Change -24.02% -13.47%
Gross Profit Margin 91.32% 92.16%
Selling, General & Admin $6.420M $6.542M
YoY Change -23.97% -27.72%
% of Gross Profit 48.6% 44.64%
Research & Development $1.440M $1.138M
YoY Change -18.27% -30.18%
% of Gross Profit 10.9% 7.76%
Depreciation & Amortization $170.0K $176.0K
YoY Change 13.33% 36.43%
% of Gross Profit 1.29% 1.2%
Operating Expenses $6.420M $6.542M
YoY Change -23.97% -27.72%
Operating Profit $5.350M $6.976M
YoY Change -25.49% 11.51%
Interest Expense $842.0K $819.0K
YoY Change 73.25% 117.24%
% of Operating Profit 15.74% 11.74%
Other Income/Expense, Net -$4.213M $821.0K
YoY Change -966.87% 117.77%
Pretax Income $1.137M $7.797M
YoY Change -85.17% 17.55%
Income Tax $1.126M $1.724M
% Of Pretax Income 99.03% 22.11%
Net Earnings $11.00K $6.073M
YoY Change -99.81% 22.22%
Net Earnings / Revenue 0.08% 38.19%
Basic Earnings Per Share $0.00 $0.88
Diluted Earnings Per Share $0.00 $0.78
COMMON SHARES
Basic Shares Outstanding 7.066M 7.031M
Diluted Shares Outstanding 7.795M 7.782M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.43M $62.75M
YoY Change -74.08% 46.05%
Cash & Equivalents $7.332M $62.75M
Short-Term Investments $6.100M
Other Short-Term Assets $2.403M $2.611M
YoY Change -0.62% -5.71%
Inventory $385.0K $408.0K
Prepaid Expenses
Receivables $7.470M $6.132M
Other Receivables $0.00 $0.00
Total Short-Term Assets $23.69M $71.91M
YoY Change -61.0% 29.34%
LONG-TERM ASSETS
Property, Plant & Equipment $2.496M $2.849M
YoY Change -32.3% -24.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $512.0K $5.884M
YoY Change -91.15% -0.15%
Other Assets $127.0K $249.0K
YoY Change -95.36% -91.16%
Total Long-Term Assets $61.10M $11.95M
YoY Change 315.31% -18.51%
TOTAL ASSETS
Total Short-Term Assets $23.69M $71.91M
Total Long-Term Assets $61.10M $11.95M
Total Assets $84.79M $83.86M
YoY Change 12.36% 19.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $227.0K $410.0K
YoY Change -55.4% 37.58%
Accrued Expenses $5.086M $4.305M
YoY Change -38.3% -40.26%
Deferred Revenue $840.0K $996.0K
YoY Change -29.29% -22.55%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.364M $5.903M
YoY Change -36.88% -33.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $24.00K $47.00K
YoY Change -79.31% -65.94%
Total Long-Term Liabilities $24.00K $47.00K
YoY Change -79.31% -65.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.364M $5.903M
Total Long-Term Liabilities $24.00K $47.00K
Total Liabilities $6.388M $5.950M
YoY Change -37.37% -34.3%
SHAREHOLDERS EQUITY
Retained Earnings $65.89M $65.88M
YoY Change 31.6% 49.08%
Common Stock $7.000K $7.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $78.40M $77.91M
YoY Change
Total Liabilities & Shareholders Equity $84.79M $83.86M
YoY Change 12.36% 19.36%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $11.00K $6.073M
YoY Change -99.81% 22.22%
Depreciation, Depletion And Amortization $170.0K $176.0K
YoY Change 13.33% 36.43%
Cash From Operating Activities $4.934M $5.624M
YoY Change -55.93% 553.19%
INVESTING ACTIVITIES
Capital Expenditures -$33.00K $4.000K
YoY Change -111.19% -95.79%
Acquisitions
YoY Change
Other Investing Activities -$60.50M
YoY Change -339.47%
Cash From Investing Activities -$60.47M -$81.00K
YoY Change -342.17% -99.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 111.0K 11.00K
YoY Change -105.62% -107.53%
NET CHANGE
Cash From Operating Activities 4.934M 5.624M
Cash From Investing Activities -60.47M -81.00K
Cash From Financing Activities 111.0K 11.00K
Net Change In Cash -55.42M 5.554M
YoY Change -262.1% -131.36%
FREE CASH FLOW
Cash From Operating Activities $4.934M $5.624M
Capital Expenditures -$33.00K $4.000K
Free Cash Flow $4.967M $5.620M
YoY Change -54.44% 633.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001554859
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-36305
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SEMLER SCIENTIFIC, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1367393
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7896043
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62754000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57200000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
132000
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2340-2348 Walsh Avenue, Suite 2344
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95051
CY2024Q1 dei City Area Code
CityAreaCode
877
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
774-4211
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
SMLR
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7065835
CY2024Q1 us-gaap Revenues
Revenues
15903000
CY2023Q1 us-gaap Revenues
Revenues
18206000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1247000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1269000
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1138000
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1630000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3675000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5192000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2867000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3859000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
8927000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
11950000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6976000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6256000
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
819000
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
484000
CY2023Q1 smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
107000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
821000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
377000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7797000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6633000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1724000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1664000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6073000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4969000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6892742
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6701199
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7782393
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
132000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
239000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
287000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6132000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6125000
CY2024Q1 us-gaap Inventory Net
InventoryNet
408000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
65876000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
59803000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
77906000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
71795000
CY2023Q4 us-gaap Inventory Net
InventoryNet
445000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2479000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2042000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
71905000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
65944000
CY2024Q1 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2071000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2285000
CY2024Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
649000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
720000
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
512000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
512000
CY2024Q1 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
4372000
CY2023Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
4372000
CY2024Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
5372000
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
5372000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
270000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3098000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2962000
CY2024Q1 us-gaap Assets
Assets
83856000
CY2023Q4 us-gaap Assets
Assets
78065000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
410000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
402000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4305000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4502000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
996000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1120000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
192000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
176000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5903000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6200000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70000
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
47000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
70000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7134193
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7099441
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6919771
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6885019
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
214422
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
214422
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12023000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11985000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83856000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78065000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
55676000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
695000
CY2023Q1 smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-146000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4969000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
61201000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
71795000
CY2024Q1 smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-45000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6073000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
77906000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
6073000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4969000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
176000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
129000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-136000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-80000
CY2024Q1 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-189000
CY2023Q1 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-78000
CY2023Q1 us-gaap Debt Securities Trading Realized Gain
DebtSecuritiesTradingRealizedGain
305000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-55000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
48000
CY2023Q1 smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
107000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
27000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
702000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-66000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5507000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-37000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
43000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
455000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1301000
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-21000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-25000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-537000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-196000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2458000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-131000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
118000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5624000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
861000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95000
CY2023Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
500000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
20211000
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
37496000
CY2024Q1 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
77000
CY2023Q1 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
544000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18424000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
45000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
146000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
56000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-146000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5554000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17709000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57332000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23014000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62886000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5305000
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span><b style="font-weight:bold;">Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;">Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 7, 2024 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">​</span></p>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
239000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-48000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
287000
CY2024Q1 us-gaap Inventory Net
InventoryNet
408000
CY2023Q4 us-gaap Inventory Net
InventoryNet
445000
CY2024Q1 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
3185000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
3375000
CY2024Q1 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1114000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1090000
CY2024Q1 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2071000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2285000
CY2024Q1 us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
77000
CY2023Q1 us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
70000
CY2024Q1 smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
53000
CY2023Q1 smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
197000
CY2024Q1 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-189000
CY2023Q1 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-78000
CY2024Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1548000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1544000
CY2024Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
899000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
824000
CY2024Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
649000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
720000
CY2024Q1 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
74000
CY2023Q1 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
59000
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
512000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
512000
CY2024Q1 smlr Percentage Of Probability Of Equity Financing
PercentageOfProbabilityOfEquityFinancing
0.05
CY2024Q1 smlr Percentage Of Probability Of Change Of Control
PercentageOfProbabilityOfChangeOfControl
0.75
CY2024Q1 smlr Percentage Of Probability Of Payment At Maturity Or Insolvency Event
PercentageOfProbabilityOfPaymentAtMaturityOrInsolvencyEvent
0.20
CY2024Q1 us-gaap Debt Securities
DebtSecurities
4372000
CY2023Q4 us-gaap Debt Securities
DebtSecurities
4372000
CY2024Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
5372000
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
5372000
CY2024Q1 smlr Debt Security Interest Income
DebtSecurityInterestIncome
125000
CY2023 smlr Debt Security Interest Income
DebtSecurityInterestIncome
82000
CY2024Q1 smlr Debt Security Changes In Fair Value
DebtSecurityChangesInFairValue
0
CY2024Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
249000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
129000
CY2024Q1 smlr Miscellaneous Receivables
MiscellaneousReceivables
100000
CY2024Q1 smlr Long Term Deposits
LongTermDeposits
20000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
150000
CY2023Q4 smlr Miscellaneous Receivables
MiscellaneousReceivables
100000
CY2023Q4 smlr Long Term Deposits
LongTermDeposits
20000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2045000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2008000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1883000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1991000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
377000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
503000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4305000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4502000
CY2024Q1 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
6981000
CY2023Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
5465000
CY2024Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
45453000
CY2024Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
10452000
CY2023Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
10494000
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
41373000
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P61M
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P61M
CY2024Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P18M
CY2024Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
22000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
22000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
70000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
71000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
141000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
138000
CY2024Q1 smlr Operating Lease Expenses In Excess Of Cash Payments
OperatingLeaseExpensesInExcessOfCashPayments
9000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
129000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
129000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
91000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47000
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.025
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7079000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
9304000
CY2024Q1 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2024Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2024Q1 smlr Defined Contribution Plan Employer Match Amount
DefinedContributionPlanEmployerMatchAmount
64000
CY2023Q1 smlr Defined Contribution Plan Employer Match Amount
DefinedContributionPlanEmployerMatchAmount
101000
CY2024Q1 smlr Income Taxes Receivable Cares Act
IncomeTaxesReceivableCaresAct
1240000
CY2023Q1 smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2024Q1 smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000.0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
148500
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4991000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
18048
CY2023Q1 smlr Share Based Compensation Arrangement By Share Based Payment Award Number Of Non Employees
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfNonEmployees
1
CY2023Q1 smlr Share Based Payment Arrangement Shares Issued Net Of Shares For Tax Withholdings
ShareBasedPaymentArrangementSharesIssuedNetOfSharesForTaxWithholdings
14099
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
695000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1021785
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.84
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M3D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41333000
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
35781
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.45
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
986004
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.89
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y1M17D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
24973000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
968872
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.49
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y11M1D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
24920000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4969000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2024Q1 smlr Amount Of Dilutive Securities Common Stock Warrants
AmountOfDilutiveSecuritiesCommonStockWarrants
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
64825
CY2023Q1 smlr Amount Of Dilutive Securities Common Stock Warrants
AmountOfDilutiveSecuritiesCommonStockWarrants
0
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
702000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1724000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1664000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2211
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2468
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
529000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
470000
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
101000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
87000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6892742
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6073000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6701199
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
889651
CY2024Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1130019
CY2023Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7782393
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6073000
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7896043
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4969000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
smlr-20240331_cal.xml Edgar Link unprocessable
0001554859-24-000017-index-headers.html Edgar Link pending
0001554859-24-000017-index.html Edgar Link pending
0001554859-24-000017.txt Edgar Link pending
0001554859-24-000017-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smlr-20240331.xsd Edgar Link pending
smlr-20240331x10q.htm Edgar Link pending
smlr-20240331xex31d1.htm Edgar Link pending
smlr-20240331xex31d2.htm Edgar Link pending
smlr-20240331xex32d1.htm Edgar Link pending
smlr-20240331_def.xml Edgar Link unprocessable
smlr-20240331_lab.xml Edgar Link unprocessable
smlr-20240331_pre.xml Edgar Link unprocessable
smlr-20240331x10q_htm.xml Edgar Link completed